Odfjell Technology Ltd. (0ABV)
London Exchange · UK · prices in NOK · close of 21 Oct 2026
Key indicators
| Last close | NOK 60.35 |
|---|---|
| 52-week range | 52.80 – 75.60 |
| Return, 1 month / 3 months | −4.1% / +5.1% |
| Return, 1 year / 3 years | +18.3% / +44.9% |
| Trend | Below its 200-day average |
| RSI (14) | 50 |
| Volatility (1 year) | 31.8% |
| Worst drawdown (1 year) | -27.7% |
| Average daily value traded | 0.01M NOK |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Odfjell Technology is an offshore oilfield services company based in Norway. It supplies drilling equipment and related products, along with well services and engineering support, to oil and gas operators working offshore. Its customers are energy companies and drilling contractors that need equipment and technical services for their offshore operations. The company also offers maintenance and modification work for offshore installations, drawing on engineering and field experience to keep drilling and well operations running.
The shares are listed on the London Exchange in UK under the code 0ABV, and the price on this page is in Norwegian kroner (NOK). Our dividend records, which start in 2019, show payments in 4 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Odfjell Technology Ltd. (0ABV) trades on the London Exchange in UK. It last closed at NOK 60.35 on 21 October 2026.
Its price-based Market X-Ray is 46 out of 100 (a weak price profile), ranking 2,308 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 18.3% and over the last three months it rose 5.1%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 42 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -2.6% | ||
| From 52-week high | -19.2% | ||
| Momentum | 59 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 5.1% | ||
| 6-month return | -7.4% | ||
| 12-month return, skipping the last month | 23.3% | ||
| Stability (higher is calmer) | 56 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 31.8% | ||
| Worst drawdown, 1 year (smaller is calmer) | -27.7% | ||
| Liquidity | 15 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.01M NOK | ||
| Zero-volume days | 1.7% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 4 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | −2.8% |
|---|---|
| 1 month | −4.1% |
| 3 months | +5.1% |
| 6 months | −7.4% |
| 1 year | +18.3% |
| 3 years | +44.9% |
| 5 years | – |
Signals
| 50-day / 200-day average | 60.25 / 61.93 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 1.31 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 10 Mar 2026 | GBP 1.5200 |
| 14 Nov 2025 | GBP 1.5200 |
| 29 Aug 2025 | GBP 1.5200 |
| 26 May 2025 | GBP 1.5200 |
| 25 Feb 2025 | GBP 1.5200 |
| 20 Nov 2024 | GBP 1.5200 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.